InvestorsHub Logo
Followers 80
Posts 24706
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 01/14/2019 9:28:34 AM

Monday, January 14, 2019 9:28:34 AM

Post# of 27624
CYTR - .60

CytRx Corporation Highlights Aldoxorubicin's Inclusion In New NantCell Inc. Colorectal Cancer Clinical Trial

https://www.stockscores.com/charts/charts/?ticker=cytr
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.